| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| Platelet-activating factor receptor | 0 | 2 | 0 | 2 |
| Inositol monophosphatase 1 | 6 | 0 | 0 | 6 |
| hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
| RAR-related orphan receptor gamma | 13 | 0 | 0 | 13 |
| GLI family zinc finger 3 | 11 | 0 | 0 | 11 |
| AR protein | 14 | 0 | 0 | 14 |
| aldehyde dehydrogenase 1 family, member A1 | 6 | 0 | 0 | 6 |
| retinoic acid nuclear receptor alpha variant 1 | 12 | 0 | 0 | 12 |
| retinoid X nuclear receptor alpha | 10 | 0 | 0 | 10 |
| estrogen nuclear receptor alpha | 12 | 0 | 0 | 12 |
| peroxisome proliferator-activated receptor delta | 7 | 0 | 0 | 7 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 6 | 0 | 0 | 6 |
| activating transcription factor 6 | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 6 | 0 | 0 | 6 |
| Histone H2A.x | 5 | 0 | 0 | 5 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| heat shock protein beta-1 | 6 | 0 | 0 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 12 | 0 | 0 | 12 |
| lamin isoform A-delta10 | 10 | 0 | 0 | 10 |
| Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
| Glutamate receptor 2 | 6 | 0 | 0 | 6 |
| acetylcholinesterase | 5 | 0 | 0 | 5 |
| thioredoxin reductase | 6 | 0 | 0 | 6 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| progesterone receptor | 7 | 0 | 0 | 7 |
| glucocorticoid receptor [Homo sapiens] | 10 | 0 | 0 | 10 |
| estrogen-related nuclear receptor alpha | 10 | 0 | 0 | 10 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
| euchromatic histone-lysine N-methyltransferase 2 | 7 | 0 | 0 | 7 |
| aryl hydrocarbon receptor | 5 | 0 | 0 | 5 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 7 | 0 | 0 | 7 |
| DNA polymerase iota isoform a (long) | 5 | 0 | 0 | 5 |
| geminin | 8 | 0 | 0 | 8 |
| muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
| Cellular tumor antigen p53 | 4 | 0 | 0 | 4 |
| Delta-aminolevulinic acid dehydratase | 0 | 1 | 0 | 1 |
| Isocitrate lyase 1 | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| 5-hydroxytryptamine receptor 3E | 0 | 3 | 0 | 3 |
| Luciferase | 2 | 0 | 0 | 2 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| Fumarate hydratase | 2 | 0 | 0 | 2 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| GLS protein | 4 | 0 | 0 | 4 |
| TDP1 protein | 9 | 0 | 0 | 9 |
| Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
| caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 3 | 5 | 0 | 0 | 5 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
| EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
| G | 4 | 0 | 0 | 4 |
| cytochrome P450 2D6 | 6 | 0 | 0 | 6 |
| polyprotein | 2 | 0 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| caspase-3 | 3 | 0 | 0 | 3 |
| IDH1 | 6 | 0 | 0 | 6 |
| Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform 2 | 9 | 0 | 0 | 9 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
| survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
| cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 3 | 1 | 0 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
| Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 3B | 0 | 3 | 0 | 3 |
| Bile salt export pump | 0 | 11 | 0 | 11 |
| Interferon beta | 4 | 0 | 0 | 4 |
| HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
| Albumin | 0 | 0 | 2 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 9 | 2 | 11 |
| Muscarinic acetylcholine receptor M4 | 0 | 11 | 2 | 13 |
| ATP-dependent translocase ABCB1 | 0 | 0 | 0 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 6 | 0 | 6 |
| Muscarinic acetylcholine receptor M3 | 0 | 5 | 0 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 5 | 0 | 5 |
| Cytochrome P450 3A4 | 0 | 4 | 0 | 5 |
| 5-hydroxytryptamine receptor 1A | 0 | 5 | 3 | 8 |
| 5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 6 |
| Muscarinic acetylcholine receptor M5 | 0 | 5 | 0 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 9 | 1 | 10 |
| Alpha-2A adrenergic receptor | 0 | 6 | 0 | 6 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 3 | 0 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 7 | 1 | 8 |
| Muscarinic acetylcholine receptor M1 | 0 | 10 | 4 | 15 |
| Cytochrome P450 2C9 | 0 | 1 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 5 | 0 | 5 |
| D(2) dopamine receptor | 0 | 6 | 0 | 9 |
| 5-hydroxytryptamine receptor 2A | 0 | 6 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 1 | 0 | 4 |
| Alpha-1B adrenergic receptor | 0 | 6 | 1 | 7 |
| Alpha-2B adrenergic receptor | 0 | 6 | 0 | 6 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 1 | 0 | 4 |
| Alpha-2C adrenergic receptor | 0 | 6 | 0 | 6 |
| D | 0 | 4 | 0 | 4 |
| D(3) dopamine receptor | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 1A | 0 | 6 | 0 | 6 |
| Alpha-2B adrenergic receptor | 0 | 4 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 1 | 0 | 4 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 10 | 2 | 12 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 6 | 0 | 7 |
| D(4) dopamine receptor | 0 | 5 | 0 | 7 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
| Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 4 | 1 | 5 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 4 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 1 | 0 | 4 |
| Alpha-1D adrenergic receptor | 0 | 6 | 1 | 7 |
| Sodium-dependent noradrenaline transporter | 0 | 5 | 1 | 6 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 6 | 0 | 6 |
| Adenosine receptor A1 | 0 | 4 | 0 | 5 |
| Alpha-1D adrenergic receptor | 0 | 6 | 0 | 6 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 6 | 0 | 8 |
| 5-hydroxytryptamine receptor 2C | 0 | 6 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 1 | 0 | 4 |
| 5-hydroxytryptamine receptor 1B | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 1 | 0 | 4 |
| D(4) dopamine receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 1F | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 6 | 1 | 7 |
| Histamine H1 receptor | 0 | 3 | 0 | 3 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 7 | 0 | 7 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C19 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
| Alpha-1A adrenergic receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 6 | 3 | 11 |
| Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
| D(3) dopamine receptor | 0 | 6 | 0 | 8 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 6 | 1 | 7 |
| Alpha-1A adrenergic receptor | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 3A | 0 | 3 | 0 | 3 |
| Histamine H2 receptor | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 5 | 0 | 6 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 2 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 3 | 0 | 3 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 5 | 0 | 0 | 5 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 6 | 0 | 6 |
| Calmodulin | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 1 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 7 | 0 | 7 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Transporter | 0 | 3 | 0 | 3 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 3D | 0 | 3 | 0 | 3 |
| Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3C | 0 | 3 | 0 | 3 |
| GABA theta subunit | 3 | 1 | 0 | 4 |
| Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
| Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
| D | 0 | 2 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
| Ataxin-2 | 2 | 0 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 3 | 1 | 0 | 4 |
| Histamine H4 receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Transporter | 0 | 3 | 0 | 3 |
| Histamine H3 receptor | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| GALC protein | 3 | 0 | 0 | 3 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
| pregnane X nuclear receptor | 8 | 0 | 0 | 8 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 0 | 3 | 3 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Mineralocorticoid receptor | 0 | 1 | 1 | 2 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| SMAD family member 2 | 3 | 0 | 0 | 3 |
| SMAD family member 3 | 3 | 0 | 0 | 3 |
| peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 3 | 0 | 3 |
| Alpha-synuclein | 3 | 0 | 0 | 3 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 3 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| Estrogen receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 2 | 1 | 3 |
| Progesterone receptor | 0 | 2 | 1 | 3 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Androgen receptor | 0 | 2 | 2 | 4 |
| Androgen receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 1 | 1 | 2 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| T cell receptor, partial | 1 | 0 | 0 | 1 |
| luteinizing hormone receptor | 1 | 0 | 0 | 1 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| TSHR protein | 1 | 0 | 0 | 1 |
| Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| Smad3 | 2 | 0 | 0 | 2 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
| Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
| Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Cruzipain | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
| Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
| Histidine decarboxylase | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 3 | 1 | 5 |
| Delta-type opioid receptor | 0 | 2 | 1 | 3 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
| Mu-type opioid receptor | 0 | 2 | 1 | 3 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
| Mu-type opioid receptor | 0 | 2 | 2 | 6 |
| Delta-type opioid receptor | 0 | 2 | 2 | 6 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 3 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 6 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 1 | 4 |
| Mu-type opioid receptor | 0 | 2 | 1 | 4 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| Acetylcholinesterase | 0 | 2 | 0 | 3 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 4 | 0 | 4 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 4 | 0 | 5 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 2 | 0 | 3 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
| USP1 protein, partial | 1 | 0 | 0 | 1 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 2 | 5 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 1 | 5 |
| Adenosine receptor A2a | 0 | 1 | 0 | 3 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
| Chitotriosidase-1 | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 0 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
| Endochitinase B1 | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| Endolysin | 0 | 0 | 1 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |